Literature DB >> 26912672

The multifactorial nature of microRNAs in vascular remodelling.

S M J Welten1, E A C Goossens1, P H A Quax1, A Y Nossent2.   

Abstract

Vascular remodelling is a multifactorial process that involves both adaptive and maladaptive changes of the vessel wall through, among others, cell proliferation and migration, but also apoptosis and necrosis of the various cell types in the vessel wall. Vascular remodelling can be beneficial, e.g. during neovascularization after ischaemia, as well as pathological, e.g. during atherosclerosis and aneurysm formation. In recent years, it has become clear that microRNAs are able to target many genes that are involved in vascular remodelling processes and either can promote or inhibit structural changes of the vessel wall. Since many different processes of vascular remodelling are regulated by similar mechanisms and factors, both positive and negative vascular remodelling can be affected by the same microRNAs. A large number of microRNAs has been linked to various aspects of vascular remodelling and indeed, several of these microRNAs regulate multiple vascular remodelling processes, including both the adaptive processes angiogenesis and arteriogenesis as well as maladaptive processes of atherosclerosis, restenosis and aneurysm formation. Here, we discuss the multifactorial role of microRNAs and microRNA clusters that were reported to play a role in multiple forms of vascular remodelling and are clearly linked to cardiovascular disease (CVD). The microRNAs reviewed are miR-126, miR-155 and the microRNA gene clusters 17-92, 23/24/27, 143/145 and 14q32. Understanding the contribution of these microRNAs to the entire spectrum of vascular remodelling processes is important, especially as these microRNAs may have great potential as therapeutic targets for treatment of various CVDs. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author 2016. For permissions please email: journals.permissions@oup.com.

Entities:  

Keywords:  Angiogenesis; Atherosclerosis; MicroRNA; Vascular remodelling

Mesh:

Substances:

Year:  2016        PMID: 26912672     DOI: 10.1093/cvr/cvw039

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  56 in total

1.  Exercise Training Restores the Cardiac Microrna-16 Levels Preventing Microvascular Rarefaction in Obese Zucker Rats.

Authors:  Tiago Fernandes; Lilian Casaes; Úrsula Soci; Andre Silveira; João Gomes; Diego Barretti; Fernanda Roque; Edilamar Oliveira
Journal:  Obes Facts       Date:  2018-02-07       Impact factor: 3.942

2.  miR-126: a potential new key player in hypoxia and reperfusion?

Authors:  Sabina P W Guenther; Sonja Schrepfer
Journal:  Ann Transl Med       Date:  2016-10

3.  MicroRNA-411 and Its 5'-IsomiR Have Distinct Targets and Functions and Are Differentially Regulated in the Vasculature under Ischemia.

Authors:  Reginald V C T van der Kwast; Tamar Woudenberg; Paul H A Quax; A Yaël Nossent
Journal:  Mol Ther       Date:  2019-10-07       Impact factor: 11.454

Review 4.  Circulating microRNA profiles in different arterial territories of stable atherosclerotic disease: a systematic review.

Authors:  Tiago Pereira-da-Silva; Madalena Coutinho Cruz; Catarina Carrusca; Rui Cruz Ferreira; Patrícia Napoleão; Miguel Mota Carmo
Journal:  Am J Cardiovasc Dis       Date:  2018-02-05

5.  Senescence-associated miR-34a and miR-126 in middle-aged Indians with type 2 diabetes.

Authors:  Joyita Banerjee; Swagata Roy; Yogita Dhas; Neetu Mishra
Journal:  Clin Exp Med       Date:  2019-11-15       Impact factor: 3.984

6.  MicroRNA-615-5p Regulates Angiogenesis and Tissue Repair by Targeting AKT/eNOS (Protein Kinase B/Endothelial Nitric Oxide Synthase) Signaling in Endothelial Cells.

Authors:  Basak Icli; Winona Wu; Denizhan Ozdemir; Hao Li; Henry S Cheng; Stefan Haemmig; Xin Liu; Giorgio Giatsidis; Seyma Nazli Avci; Nathan Lee; Raphael Boesch Guimaraes; Andre Manica; Julio F Marchini; Stein Erik Rynning; Ivar Risnes; Ivana Hollan; Kevin Croce; Xianbin Yang; Dennis P Orgill; Mark W Feinberg
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-05-16       Impact factor: 8.311

7.  C/D box snoRNA SNORD113-6/AF357425 plays a dual role in integrin signalling and arterial fibroblast function via pre-mRNA processing and 2'O-ribose methylation.

Authors:  Eva van Ingen; Daphne A L van den Homberg; M Leontien van der Bent; Hailiang Mei; Nikolina Papac-Milicevic; Veerle Kremer; Reinier A Boon; Paul H A Quax; Johann Wojta; A Yaël Nossent
Journal:  Hum Mol Genet       Date:  2022-03-31       Impact factor: 6.150

Review 8.  Non-coding RNAs in cardiovascular diseases: diagnostic and therapeutic perspectives.

Authors:  Wolfgang Poller; Stefanie Dimmeler; Stephane Heymans; Tanja Zeller; Jan Haas; Mahir Karakas; David-Manuel Leistner; Philipp Jakob; Shinichi Nakagawa; Stefan Blankenberg; Stefan Engelhardt; Thomas Thum; Christian Weber; Benjamin Meder; Roger Hajjar; Ulf Landmesser
Journal:  Eur Heart J       Date:  2018-08-01       Impact factor: 29.983

Review 9.  Diagnostic and prognostic potential of circulating miRNAs for intracranial aneurysms.

Authors:  Ilgiz Gareev; Ozal Beylerli; Guang Yang; Adel Izmailov; Huaizhang Shi; Jinxian Sun; Boxian Zhao; Binbing Liu; Shiguang Zhao
Journal:  Neurosurg Rev       Date:  2020-10-23       Impact factor: 3.042

10.  miR155 Deficiency Reduces Myofibroblast Density but Fails to Improve Cardiac Function after Myocardial Infarction in Dyslipidemic Mouse Model.

Authors:  David Schumacher; Adelina Curaj; Sakine Simsekyilmaz; Andreas Schober; Elisa A Liehn; Sebastian F Mause
Journal:  Int J Mol Sci       Date:  2021-05-22       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.